Search Results - "Adamkewicz, Joanne I." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

by Mahlangu, Johnny, Oldenburg, Johannes, Paz-Priel, Ido, Negrier, Claude, Niggli, Markus, Mancuso, M. Elisa, Schmitt, Christophe, Jiménez-Yuste, Victor, Kempton, Christine, Dhalluin, Christophe, Callaghan, Michael U, Bujan, Willem, Shima, Midori, Adamkewicz, Joanne I, Asikanius, Elina, Levy, Gallia G, Kruse-Jarres, Rebecca
Published in The New England journal of medicine (30.08.2018)

Get full text

Journal Article

Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer

Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer

by Marshall, Derek C, Lyman, Susan K, McCauley, Scott, Kovalenko, Maria, Spangler, Rhyannon, Liu, Chian, Lee, Michael, O'Sullivan, Christopher, Barry-Hamilton, Vivian, Ghermazien, Haben, Mikels-Vigdal, Amanda, Garcia, Carlos A, Jorgensen, Brett, Velayo, Arleene C, Wang, Ruth, Adamkewicz, Joanne I, Smith, Victoria
Published in PloS one (11.05.2015)

Get full text

Journal Article

Effects and Interferences of Emicizumab, a Humanised Bispecific Antibody Mimicking Activated Factor VIII Cofactor Function, on Coagulation Assays

Effects and Interferences of Emicizumab, a Humanised Bispecific Antibody Mimicking Activated Factor VIII Cofactor Function, on Coagulation Assays

by Adamkewicz, Joanne I., Chen, David C., Paz-Priel, Ido
Published in Thrombosis and haemostasis (01.07.2019)

Get full text

Journal Article

High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888

High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888

by Lyman, Susan K, Crawley, Suzanne C, Gong, Ruoyu, Adamkewicz, Joanne I, McGrath, Garth, Chew, Jason Y, Choi, Jennifer, Holst, Charles R, Goon, Leanne H, Detmer, Scott A, Vaclavikova, Jana, Gerritsen, Mary E, Blake, Robert A
Published in PloS one (07.03.2011)

Get full text

Journal Article

Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study

Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study

by Schmitt, Christophe, Adamkewicz, Joanne I., Xu, Jin, Petry, Claire, Catalani, Olivier, Young, Guy, Negrier, Claude, Callaghan, Michael U., Levy, Gallia G.
Published in Thrombosis and haemostasis (01.03.2021)

Get full text

Journal Article

SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment

SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment

by Sodir, Nicole M, Pathria, Gaurav, Adamkewicz, Joanne I, Kelley, Elizabeth H, Sudhamsu, Jawahar, Merchant, Mark, Chiarle, Roberto, Maddalo, Danilo
Published in Cancer discovery (01.11.2023)

Get full text

Journal Article

Effect of emicizumab prophylaxis on bone and joint health markers in people with haemophilia A without factor VIII inhibitors in the HAVEN 3 study

Effect of emicizumab prophylaxis on bone and joint health markers in people with haemophilia A without factor VIII inhibitors in the HAVEN 3 study

by Kiialainen, Anna, Niggli, Markus, Kempton, Christine L., Castaman, Giancarlo, Chang, Tiffany, Paz‐Priel, Ido, Adamkewicz, Joanne I., Levy, Gallia G.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.11.2022)

Get full text

Journal Article

Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure

Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure

by Karsdal, Morten A, Nielsen, Mette J, Sand, Jannie M, Henriksen, Kim, Genovese, Federica, Bay-Jensen, Anne-Christine, Smith, Victoria, Adamkewicz, Joanne I, Christiansen, Claus, Leeming, Diana J
Published in Assay and drug development technologies (01.03.2013)

Get more information

Journal Article

Clinical pharmacology of emicizumab for the treatment of hemophilia A

Clinical pharmacology of emicizumab for the treatment of hemophilia A

by Yoneyama, Koichiro, Schmitt, Christophe, Portron, Agnès, Kiialainen, Anna, Kotani, Naoki, Jaminion, Felix, Retout, Sylvie, Adamkewicz, Joanne I
Published in Expert review of clinical pharmacology (02.09.2023)

Get more information

Journal Article

Correction: High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888

Correction: High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888

by Lyman, Susan K., Crawley, Suzanne C., Gong, Ruoyu, Adamkewicz, Joanne I., McGrath, Garth, Chew, Jason Y., Choi, Jennifer, Holst, Charles R., Goon, Leanne H., Detmer, Scott A., Vaclavikova, Jana, Gerritsen, Mary E., Blake, Robert A.
Published in PloS one (21.03.2011)

Get full text

Journal Article

Effects and interferences of emicizumab, a humanized bispecific antibody mimicking activated factor VIII cofactor function, on lupus anticoagulant assays

Effects and interferences of emicizumab, a humanized bispecific antibody mimicking activated factor VIII cofactor function, on lupus anticoagulant assays

by Adamkewicz, Joanne I., Kiialainen, Anna, Paz‐Priel, Ido
Published in International journal of laboratory hematology (01.04.2020)

Get full text

Journal Article

Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks

Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks

by Kiialainen, Anna, Adamkewicz, Joanne I., Petry, Claire, Oldenburg, Johannes, Pipe, Steven W., Young, Guy, Mahlangu, Johnny, Lehle, Michaela, Niggli, Markus, Castaman, Giancarlo, Jiménez-Yuste, Víctor, Shima, Midori, Négrier, Claude, Schmitt, Christophe
Published in Research and practice in thrombosis and haemostasis (01.01.2024)

Get full text

Journal Article

Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression

Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression

by CHIEN, Jason W, RICHARDS, Thomas J, O'RIORDAN, Thomas, GIBSON, Kevin F, YINGZE ZHANG, LINDELL, Kathleen O, LIXIN SHAO, LYMAN, Susan K, ADAMKEWICZ, Joanne I, SMITH, Victoria, KAMINSKI, Naftali
Published in The European respiratory journal (01.05.2014)

Get full text

Journal Article

ANTIBODIES TO MATRIX METALLOPROTEINASE 9

ANTIBODIES TO MATRIX METALLOPROTEINASE 9

by ADAMKEWICZ JOANNE I, SMITH VICTORIA, THAI ZUNG, HAWKINS MICHAEL J
Year of Publication 10.11.2014

Get full text

Patent

High Affinity Interaction of Yeast Transcriptional Regulator, Mot1, with TATA Box-binding Protein (TBP)

High Affinity Interaction of Yeast Transcriptional Regulator, Mot1, with TATA Box-binding Protein (TBP)

by Adamkewicz, Joanne I., Hansen, Karin E., Prud'homme, Wendy A., Davis, Jennifer L., Thorner, Jeremy
Published in The Journal of biological chemistry (13.04.2001)

Get full text

Journal Article

Purification and Enzymic Properties of Mot1 ATPase, a Regulator of Basal Transcription in the Yeast Saccharomyces cerevisiae

Purification and Enzymic Properties of Mot1 ATPase, a Regulator of Basal Transcription in the Yeast Saccharomyces cerevisiae

by Adamkewicz, Joanne I., Mueller, Christopher G.F., Hansen, Karin E., Prud'homme, Wendy A., Thorner, Jeremy
Published in The Journal of biological chemistry (14.07.2000)

Get full text

Journal Article

THERAPEUTIC AND DIAGNOSTIC METHODS RELATED TO LYSYL OXIDASE-LIKE 2 (LOXL2)

THERAPEUTIC AND DIAGNOSTIC METHODS RELATED TO LYSYL OXIDASE-LIKE 2 (LOXL2)

by ADAMKEWICZ JOANNE I, SMITH VICTORIA, LI XIAOMING, LYMAN SUSAN K, BORNSTEIN JEFFREY D, SHAO LIXIN, CHIEN JASON
Year of Publication 01.07.2015

Get full text

Patent

Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3

Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3

by Kiialainen, Anna, Niggli, Markus, Kempton, Christine L., Castaman, Giancarlo, Chang, Tiffany Y., Paz-Priel, Ido, Adamkewicz, Joanne I, Levy, Gallia G.
Published in Blood (13.11.2019)

Get full text

Journal Article

LYSYL OXIDASE-LIKE 2 ASSAY AND METHODS OF USE THEREOF

LYSYL OXIDASE-LIKE 2 ASSAY AND METHODS OF USE THEREOF

by ADAMKEWICZ JOANNE I, SMITH VICTORIA, LI XIAOMING, LYMAN SUSAN K, BORNSTEIN JEFFREY D, SHAO LIXIN, CHIEN JASON
Year of Publication 23.04.2014

Get full text

Patent

Use of Bypassing Agents Prior to and Post Bypassing Agent Dosing Guidance during Emicizumab Prophylaxis: Analyses from the HAVEN 1 Study

Use of Bypassing Agents Prior to and Post Bypassing Agent Dosing Guidance during Emicizumab Prophylaxis: Analyses from the HAVEN 1 Study

by Callaghan, Michael U., Negrier, Claude, Young, Guy, Khoo, Liane, Mahlangu, Johnny, Windyga, Jerzy, Oldenburg, Johannes, Xu, Jin, Catalani, Olivier, Asikanius, Elina, Adamkewicz, Joanne I., Shima, Midori
Published in Blood (08.12.2017)

Get full text

Journal Article

1
2
3
4
5
6
7
8
Next
[8]